Established in 2005, Jilin Qijian Bio-Pharmaceutical Co., Ltd. is a cGMP approved pharmaceutical company in China. We specialized in the R&D, production and sales of APIs and FDFs to global customers. Our hGH API got certificate of EU-WC, also filed in US-FDA DMF. The factory covers an area of 30,000 square meters, with 16,000 square meters of production workshops including standard genetic engineering production lines, biochemical synthesis production lines, chemical synthesis production lines, sterilized freeze-dried system and small volume injection production lines complying with the GMP regulations. Over 20 years of development, Qijian professionals are constantly committed to developing, manufacturing and commercializing innovative chemical & biological pharmaceuticals covering many therapeutic areas, including cerebrovascular nerve repair, endocrinology, anti-aging and liver disease, etc. Qijian adheres to the concept of "responsibility, innovation, and integrity", focuses on human health and well-being, changes the future through technology, and achieves beyond user expectations. The main products are gene recombinant protein(Somatropin), butyphalide,Monosialotetrahexosylganglioside Sodium (GM1) and Ademetionine 1,4-Butanedisulfonate (SAM), cliclitiede etc.